Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1986 Aug;41(8):606–610. doi: 10.1136/thx.41.8.606

Value of serial peak expiratory flow measurements in assessing treatment response in chronic airflow limitation.

D M Mitchell, P Gildeh, A H Dimond, J V Collins
PMCID: PMC460405  PMID: 3538487

Abstract

A double blind, randomised, placebo controlled, crossover trial of prednisolone (40 mg/day for 14 days) was carried out in 33 patients with chronic airflow limitation (mean age 62 years, mean FEV1 1.01 litres, mean FEV1/FVC ratio 44%), to assess the value of serial peak expiratory flow (PEF) measurements, taken five times daily in evaluating treatment response by comparison with other objective measurements and with measurements of symptoms. The mean serial PEF after a one week run in period was 189 1 min-1, during the second week of placebo 193 1 min-1, and during the second week on prednisolone 231 1 min-1. The difference in mean PEF values between placebo and prednisolone was significant (p less than 0.01). With regard to the response to steroids of the individual patients, 13 of the 33 had a detectable trend of improvement on visual inspection of serial PEF measurements during prednisolone treatment but only one during placebo administration. Of all the objective measurements made after the run in and after each treatment phase (12 minute walking distance, FEV1, forced vital capacity (FVC), serial PEF), the serial PEF chart provided the best discrimination between placebo and prednisolone treatment. There was no statistically significant association between steroid induced improvement in serial PEF measurements and in breathlessness, partly because of placebo improvements in symptoms in those who had no improvement in serial PEF values. This study indicates the importance of making objective measurements to identify a genuine steroid response rather than relying on symptomatic improvement alone. The best simple measurement to make is serial PEF during steroid trials. This is more sensitive in detecting a steroid response than are the 12 minute walking distance, FEV1, or FVC, and is also less likely than these measurements to show spurious placebo responses.

Full text

PDF
606

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Dawkins K. D., Muers M. F. Diurnal variation in airflow obstruction in chronic bronchitis. Thorax. 1981 Aug;36(8):618–621. doi: 10.1136/thx.36.8.618. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. FLETCHER C. M., ELMES P. C., FAIRBAIRN A. S., WOOD C. H. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br Med J. 1959 Aug 29;2(5147):257–266. doi: 10.1136/bmj.2.5147.257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Harding S. M., Freedman S. A comparison of oral and inhaled steroids in patients with chronic airways obstruction: features determining response. Thorax. 1978 Apr;33(2):214–218. doi: 10.1136/thx.33.2.214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Hetzel M. R., Clark T. J. Comparison of normal and asthmatic circadian rhythms in peak expiratory flow rate. Thorax. 1980 Oct;35(10):732–738. doi: 10.1136/thx.35.10.732. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hetzel M. R. The pulmonary clock. Thorax. 1981 Jul;36(7):481–486. doi: 10.1136/thx.36.7.481. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. McGavin C. R., Artvinli M., Naoe H., McHardy G. J. Dyspnoea, disability, and distance walked: comparison of estimates of exercise performance in respiratory disease. Br Med J. 1978 Jul 22;2(6132):241–243. doi: 10.1136/bmj.2.6132.241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Mendella L. A., Manfreda J., Warren C. P., Anthonisen N. R. Steroid response in stable chronic obstructive pulmonary disease. Ann Intern Med. 1982 Jan;96(1):17–21. doi: 10.7326/0003-4819-96-1-17. [DOI] [PubMed] [Google Scholar]
  8. Mitchell D. M., Collins J. V., Morley J. An evaluation of cusum analysis in asthma. Br J Dis Chest. 1980 Apr;74(2):169–174. doi: 10.1016/0007-0971(80)90029-7. [DOI] [PubMed] [Google Scholar]
  9. Sahn S. A. Corticosteroids in chronic bronchitis and pulmonary emphysema. Chest. 1978 Mar;73(3):389–396. doi: 10.1378/chest.73.3.389. [DOI] [PubMed] [Google Scholar]
  10. Turner-Warwick M. On observing patterns of airflow obstruction in chronic asthma. Br J Dis Chest. 1977 Apr;71(2):73–86. doi: 10.1016/0007-0971(77)90086-9. [DOI] [PubMed] [Google Scholar]
  11. Webb J., Clark T. J. Recovery of plasma corticotrophin and cortisol levels after three-week course of prednisolone. Thorax. 1981 Jan;36(1):22–24. doi: 10.1136/thx.36.1.22. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES